BEACON Study Investigator Meeting

We are pleased to invite you to the BEACON Study Investigator Meeting on January 22-23, 2027 in Fort Lauderdale, Florida at the Pier Sixty-Six Hotel.

The meeting will feature a rich, scientifically focused program, including presentations from Drs. Bill Damsky, Misha Rosenbach, and Avrom Caplan, as well as Priovant (sponsor) executives. The agenda will include high-yield sessions including a deep dive into brepocitinib’s development history, mechanistic insights into the value of TYK2/JAK1 inhibition in cutaneous sarcoidosis, highlights from the study protocol, training on pertinent outcome assessments, and practical strategies for patient selection, recruitment, and high-quality trial execution.

Registration for the BEACON Study Investigator Meeting is due by December 18, 2026. If you have any questions regarding this meeting, please contact Whitney Holmes at whitney.holmes@priovant.com.